Industries Insiders Forms Rankings Articles

Home / Theravance Biopharma, Inc. / Filings / SC 13G/A

SC 13G/A

SCHEDULE 13G (AMENDMENT NO. 1)

Company: Theravance Biopharma, Inc.
Filed: February 14, 2022
Accession Number: 0000899140-22-000327

View Document ↗ View on SEC.gov ↗

Browse

By Industry
By Exchange
By State
Insider Buying
Insider Selling
Cluster Buys
Executive Buying

Popular Industries

Software
Banking
Pharmaceuticals
Semiconductors
All Industries

Resources

Filing Types Explained
Top Companies by Revenue
Most Profitable Companies
Highest Profit Margins
Recent IPO Filings (S-1)
Amended Filings
Revenue Growth Streaks
New SEC Filers
Articles
Data Sources
SEC EDGAR

Legal

Disclaimer
Privacy Policy
Terms of Use

© 2026 EdgarLookup. All rights reserved. Filing data sourced from the SEC EDGAR database. For informational purposes only — not financial advice. · Data last updated 3 months ago.